DEXTROSE INJECTION,

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of one package of DEXTROSE INJECTION, identified by NSN 6505013318941 and NDC 00264-7510-20, at a total cost of $135.05. The award was issued on July 14, 2026, with a required delivery date of July 29, 2026, under FOB destination terms, meaning the contractor bears all transportation costs and risks until the item is received at the specified delivery point: FY2932 81ST MDG SGL, KEESSLER AFB MS 39534 US. The contract is classified as a small business set-aside, with the awardee certified as a Small Disadvantaged Business and a Women-Owned Small Business, triggering compliance with federal socioeconomic reporting and verification requirements. Packaging must support traceable shipping using the fastest available method, explicitly prohibiting parcel post, and all packages and documentation must be clearly marked with procurement identification numbers from Blocks 1 and 2. Inspection and acceptance occur at the destination, with payment processed by Defense Finance and Accounting Service at the remit-to address in Keesler AFB, Mississippi, using the provided D.O. Voucher and S/R Voucher numbers. The contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena, while no contracting officer representative is listed. The award reflects a streamlined, low-value procurement executed under simplified acquisition procedures, likely on a Lowest Price Technically Acceptable basis, with no options, additional line items, or detailed technical specifications beyond the product description and compliance with DoD unit of issue standards. No explicit FAR clauses, MIL-STD packaging requirements, or bar-coding standards are included in the document, suggesting these are incorporated by reference from the underlying indefinite-delivery contract.